RecruitingNCT07588971

Natural History and Prognosis of Pediatric Epilepsies With Different Etiology

Natural History and Prognosis of Pediatric Epilepsies With Different Etiology: Long-term Study


Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment

2,300 participants

Start Date

Oct 26, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Epilepsy is one of the most common neurological diseases in Italy, affecting about 500,000 people. Pediatric age represents one of the most affected groups with a consequent significant impact on the quality of life of the families involved. The study aims to monitor the cognitive functions of patients followed at our center in order to determine the main types of pathways and highlight their determinants. The ultimate goal is to define what are the main clinical and instrumental predictors of cognitive function and its variation over time.


Eligibility

Max Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with pediatric epilepsies. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Rome, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07588971